|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM228414806 |
003 |
DE-627 |
005 |
20231224075845.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2013 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2013.05.010
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0761.xml
|
035 |
|
|
|a (DE-627)NLM228414806
|
035 |
|
|
|a (NLM)23773920
|
035 |
|
|
|a (PII)S1521-6616(13)00130-7
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Maier-Moore, Jacen S
|e verfasserin
|4 aut
|
245 |
1 |
4 |
|a The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians
|
264 |
|
1 |
|c 2013
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 17.09.2013
|
500 |
|
|
|a Date Revised 16.07.2022
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
650 |
|
4 |
|a Letter
|
650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
650 |
|
4 |
|a CCR5 delta 32
|
650 |
|
4 |
|a Sjögren's syndrome
|
650 |
|
4 |
|a Type 1 Diabetes
|
650 |
|
4 |
|a rs333
|
650 |
|
7 |
|a Receptors, CCR5
|2 NLM
|
700 |
1 |
|
|a Cañas, Carlos A
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tobón, Gabriel
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Arango, Alvaro
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Anaya, Juan-Manuel
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Scofield, R Hal
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 148(2013), 2 vom: 17. Aug., Seite 206-8
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:148
|g year:2013
|g number:2
|g day:17
|g month:08
|g pages:206-8
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2013.05.010
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 148
|j 2013
|e 2
|b 17
|c 08
|h 206-8
|